Comparison of Yttrium-90 therapy for unresectable liver metastasis: glass versus biocompatible resin microspheres

ConclusionsTheraSphere microsphere appears superior to SIR-Spheres in treating non-HCC intrahepatic malignancy. However, patient selection and better multi-disciplinary care may play a role in these differences. Continued studies in combination therapies for all hepatic malignancies is critical to the long-term success and sustainability of Y-90 therapy.
Source: Journal of Radiation Oncology - Category: Cancer & Oncology Source Type: research